Search

Your search keyword '"Calvin, Andrew D."' showing total 32 results
Start Over Author "Calvin, Andrew D." Publication Year Range Last 10 years
32 results on '"Calvin, Andrew D."'

5. Adopting academic rank in a rural community practice affiliated with an academic medical center.

Author

Calvin, Andrew D., Dexter, Donn, Beckermann, Jason, Hayes, Sharonne N., Manning, Carmen K., and Helmers, Richard A.

Subjects
TEACHER development, RURAL Americans, TEACHING awards, ACADEMIC medical centers, RURAL health
Abstract

Background: United States rural community-based practices are increasingly participating in undergraduate and graduate medical education to train the workforce of the future, and are required or encouraged to provide academic appointments to physicians who have typically not held an academic appointment. Mechanisms to identify faculty and award academic appointments across an entire health system have not been reported. Methods: Our rural community regional practice identified academic appointments as important for participating in medical education. Over a three-year period, our regional leadership organized a formal education committee that led a variety of administrative changes to promote the adoption of academic rank. Data on attainment of academic appointments was obtained from our Academic Appointment and Promotion Committee, and cross referenced with data from our regional human resources department using self-reported demographic data. Results: We describe a successful adoption strategy for awarding academic rank in a rural regional practice in which the percentage of physician staff with academic rank increased from 41.1 to 92.8% over a 3-year period. Conclusions: Our experience shows that process changes can rapidly increase and then sustain academic appointments for physicians over time. More rural health systems may want to consider the use of academic rank to support educational programs while enhancing physician satisfaction, recruitment and retention. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Life-Threatening Aortic Dissection during Pregnancy: A Case Report of Undiagnosed FBN1- Related Marfan Syndrome at 39 Weeks Gestation.

Author

Gurrieri, Carmelina, Manske, Westley T., Williams, Carla, Wildenberg, Joseph C., Keppers, Rachel J., Tallarita, Tiziano, Saran, Nishant, and Calvin, Andrew D.

Subjects
AORTIC dissection, ASCENDING aorta dissection, MARFAN syndrome, SYMPTOMS, PREGNANCY, INTENSIVE care units
Abstract

Background: Inherited deficiencies in the FBN1 gene, which encodes fibrillin-1, result in Marfan syndrome, an autosomal dominant connective tissue disorder that is associated with aortic root dilatation and predisposes to aortic dissection. This report is of a 37-year-old woman presenting at 39 weeks of pregnancy with acute thoracic aortic dissection due to previously undiagnosed FBN1-related Marfan syndrome. This case report aims to illustrate the challenges in the diagnosis and in the peri-operative management of acute aortic dissection during pregnancy. Case Report: A healthy 37-year-old woman at 39 weeks of gestation presented to our hospital with dyspnea and chest pain. Initial evaluation for pulmonary embolism with chest computed tomography was unrevealing. The patient was admitted to the intensive care unit for further management. Overnight, her clinical conditions deteriorated, and a transthoracic echocardiography was obtained, demonstrating an acute ascending aortic dissection. She emergently underwent a successful combined cesarean section and ascending aortic dissection repair, with no immediate complications. On postoperative day 4 she developed cardiac tamponade, for which she underwent emergent mediastinal exploration. She was discharged home on postoperative day 10. A month later she completed genetic testing, which revealed a pathogenic mutation in the FBN1 gene, consistent with a molecular diagnosis of Marfan syndrome. Conclusions: This report has shown that FBN1-related Marfan’s syndrome has a variable clinical presentation that can include life-threatening aortic dissection during pregnancy. Successful diagnosis and management of these patients is challenging and requires multidisciplinary expertise, including confirmation of the diagnosis by a clinical geneticist. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

25. Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300–2306

Author

Calvin, Andrew D., primary, Aggarwal, Niti R., additional, Murad, Mohammad Hassan, additional, Shi, Qian, additional, Elamin, Mohamed B., additional, Geske, Jeffrey B., additional, Fernandez-Balsells, M. Merce, additional, Albuquerque, Felipe N., additional, Lampropulos, Julianna F., additional, Erwin, Patricia J., additional, Smith, Steven A., additional, and Montori, Victor M., additional

Published
2018
Full Text
View/download PDF

29. Experimental Sleep Restriction Causes Endothelial Dysfunction in Healthy Humans

Author

Calvin, Andrew D., primary, Covassin, Naima, additional, Kremers, Walter K., additional, Adachi, Taro, additional, Macedo, Paula, additional, Albuquerque, Felipe N., additional, Bukartyk, Jan, additional, Davison, Diane E., additional, Levine, James A., additional, Singh, Prachi, additional, Wang, Shihan, additional, and Somers, Virend K., additional

Published
2014
Full Text
View/download PDF

31. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial

Author

Wolk, Robert, Bertolet, Marnie, Brooks, Maria M, Pratley, Richard E, Sobel, Burton E, Frye, Robert L, Singh, Prachi, Calvin, Andrew D, Rutter, Martin K, Mooradian, Arshag D, and Somers, Virend K

Abstract

Aims To determine the effects of insulin sensitization (IS) and insulin provision (IP) treatment strategies on adipokines associated with cardiovascular disease in patients with type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).Methods and results Changes in adipokine levels were compared in patients with type 2 diabetes mellitus and coronary artery disease randomized to IS (n= 1037) versus IP (n= 1019) treatment strategies in BARI 2D. Circulating concentrations of leptin, adiponectin, monocyte chemoattractant protein-1, tumor necrosis factor-alpha, interleukin 6 and C-reactive protein were evaluated at baseline and one year. IS and IP treatment strategies exerted significant (p< 0.0001) differential effects on: leptin (IS: 0.02% decrease, p= 0.01; IP: 13% increase, p< 0.0001); adiponectin (IS: 73% increase, p< 0.0001; IP: no change, p= 0.52); interleukin 6 (IS: 14% decrease, p< 0.0001; IP: no change, p= 0.68). Changes in monocyte chemoattractant protein-1 and tumor necrosis factor-alpha were not statistically different between groups. C-reactive protein decreased, but the effect was significantly greater in the IS group (–32%, p< 0.0001) than in the IP group (–5%, p= 0.0005).Conclusion The IS and IP treatment strategies exerted divergent effects on adipokine and inflammatory profile in patients with type 2 diabetes mellitus and coronary artery disease. The IS treatment strategy-induced changes may be more favorable than the IP treatment strategy regarding cardiovascular pathophysiology.

Published
2016
Full Text
View/download PDF

32. Amiodarone Pharmacovigilance Through an Intelligent Electronic Health Record Application.

Author

Newgaard OR, Chaudhry R, Schutte JA, Arndt R, Rich JR, Calvin AD, and Hanna RD

Subjects
Humans, Pharmacovigilance, Electronic Health Records, Drug Monitoring, Retrospective Studies, Anti-Arrhythmia Agents adverse effects, Amiodarone adverse effects
Abstract

Background: Amiodarone is the most effective and commonly used antiarrhythmic medication. Given its risk of toxicity, routine monitoring is recommended but is challenging to ensure in clinical practice., Methods: We created an intelligent application, built within our electronic health record, that identified every living patient with an active outpatient prescription by a clinician in our health system. The application was designed to identify patients with lapses in recommended monitoring and facilitate scheduling of overdue testing., Results: The percentage of patients with overdue monitoring tests decreased with use of the application, with greatest improvement in pulmonary function testing., Discussion: Implementing a program to monitor and mitigate adverse reactions to amiodarone by using programable features of an electronic health record is feasible., (Copyright© Board of Regents of the University of Wisconsin System and The Medical College of Wisconsin, Inc.)

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results